 | Up a level |
Oran, Betül; Ahn, Kwang Woo; Fretham, Caitrin; Beitinjaneh, Amer; Bashey, Asad; Pawarode, Attaphol; Wirk, Baldeep; Scott, Bart L; Savani, Bipin N; Bredeson, Christopher; Weisdorf, Daniel; Marks, David I; Rizzieri, David; Copelan, Edward; Hildebrandt, Gerhard C; Hale, Gregory A; Murthy, Hemant S; Lazarus, Hillard M; Cerny, Jan; Liesveld, Jane L; ... (2021). Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes. Transplantation and cellular therapy, 27(11), 921.e1-921.e10. Elsevier 10.1016/j.jtct.2021.08.007
Schmidt, Sarah; Liu, Ying; Hu, Zhen-Huan; Williams, Kirsten M; Lazarus, Hillard M; Vij, Ravi; Kharfan-Dabaja, Mohamed A; Ortí, Guillermo; Wiernik, Peter H; Weisdorf, Daniel; Kamble, Rammurti T; Herzig, Roger; Wirk, Baldeep; Cerny, Jan; Bacher, Ulrike; Chaudhri, Naeem A; Nathan, Sunita; Farhadfar, Nosha; Aljurf, Mahmoud; Gergis, Usama; ... (2020). The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biology of blood and marrow transplantation, 26(6), pp. 1137-1143. Elsevier 10.1016/j.bbmt.2020.02.006
DeFilipp, Zachariah; Ancheta, Richard; Liu, Ying; Hu, Zhen-Huan; Gale, Robert Peter; Snyder, David; Schouten, Harry C; Kalaycio, Matt; Hildebrandt, Gerhard C; Ustun, Celalettin; Daly, Andrew; Ganguly, Siddhartha; Inamoto, Yoshihiro; Litzow, Mark; Szer, Jeffrey; Savoie, Mary Lynn; Hossain, Nasheed; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Reshef, Ran; ... (2020). Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. Biology of blood and marrow transplantation, 26(3), pp. 472-479. Elsevier 10.1016/j.bbmt.2019.10.017
